Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Case Group (people with lung cancer):
- People who are 45 years of age or older at the time of signing the consent form
- People who have been diagnosed with small-cell or non-small-cell lung cancer, confirmed through laboratory tissue testing
- People who have not yet received any cancer treatment (such as surgery, radiation, chemotherapy, or immunotherapy) before their sample is collected
Control Group A (higher-risk people without lung cancer):
- People who are 45 years of age or older at the time of signing the consent form
- People considered at high risk for lung cancer, meaning those with a smoking history of at least 20 pack-years who currently smoke or stopped smoking within the last 15 years
- People with no diagnosis or suspicion of lung cancer, who have had a chest CT scan for lung cancer screening within the past 12 months as part of routine care, and whose scan result showed a LUNG-RADS score of 3 or lower (a low-to-moderate risk rating) (confirm with trial site)
Control Group B (lower-risk people without lung cancer):
- People who are 45 years of age or older at the time of signing the consent form
- People who do not meet the high-risk smoking criteria described in Control Group A
- People with no diagnosis or suspicion of lung cancer
Who may not be able to join:
- People with a history of any cancer, unless the cancer was caught at an early stage, treated with the intent to cure, and the person has been cancer-free for at least five years
- People diagnosed with lung cancer who have already started cancer treatment before their sample is collected
- People who have had a biopsy, invasive procedure, or minor surgery within the last 48 hours
- People who have had major surgery within the last 7 days
- People with severe kidney disease, meaning the kidneys are functioning at a very low level (glomerular filtration rate below 15 ml/min) (confirm with trial site)
- People with severe liver disease, classified as Child-Pugh C (a medical rating indicating advanced liver dysfunction) (confirm with trial site)
- People who currently have an active infection, or who finished treatment for an infection less than 4 weeks ago
- People considered part of a vulnerable group, including minors, prisoners, pregnant women, or adults who are not able to give informed consent due to physical or mental incapacity
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 917 56 79 97
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To determine the risk of developing lung cancer, expressed as a percentage, in order to assist doctors in the diagnosis of lung cancer.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.